Foghorn Therapeutics Inc. (FHTX)

Foghorn Therapeutics Revenue

Foghorn Therapeutics had revenue of $7.81M in the quarter ending September 30, 2024, a decrease of -55.33%. This brings the company's revenue in the last twelve months to $25.52M, down -21.66% year-over-year. In the year 2023, Foghorn Therapeutics had annual revenue of $34.16M with 77.63% growth.

• Revenue (ttm): $25.52M
• Revenue Growth: -21.66%
• P/S Ratio: 15.32
• Revenue / Employee: $219,957
• Employees: 116
• Market Cap: 444.19M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	34.16M	14.93M	77.63%
Dec 31, 2022	19.23M	17.91M	1,357.77%
Dec 31, 2021	1.32M	889.00K	206.74%
Dec 31, 2020	430.00K	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.